ELRIG High Content Imaging and Flow Cytometry 2025
Stevenage, UK
November 19–20, 2025
Join Genedata experts at the ELRIG High Content Imaging and Flow Cytometry in Drug Discovery conference.
Don't miss the opportunity to see how Genedata Screener® automates assay analysis, validates raw data and assay result quality, and consolidates assay information across the enterprise and external collaborators. By integrating and condensing complex experimental data, it powers project decisions and lays the foundation for more predictive, AI-driven, drug discovery and development.
If you would like to schedule a meeting in advance or receive more information on Genedata Screener, please contact screener(at)genedata.com.
Recommended Oral Presentation
Improve Efficiency of HCS Analysis Using a Deep Learning-Based Approach with Genedata Screener
Michelle Newman, Scientific Account Manager, Genedata
Wednesday, November 19 | 11:50-11:55
Image-based assays offer profound insights about candidate molecules, and with advances in technology these assays can be performed at high throughput, however their analysis can create a bottleneck. In this spotlight presentation, we will show how using a deep learning-based analysisGenedata Screener automates the entire high-content screening workflow. We will illustrate this using real-world examples from our customers, including a multiparametric cell painting assay and an aqueous compatibility brightfield assay.
Recommended Poster Presentation
A New Workflow for Efficiently Automating Analysis of Large-Scale Data for Flow Cytometry Screening (#22)
Newman M1, Nass Kovacs G1, Pietilae M1, Thomas B1, Menut P2, Vaz B2, Catteau M2, Heyse S1, Steigele S1
1Genedata AG, Basel, Switzerland | 2Evotec, Toulouse Cedex, France
Flow cytometry is a key method in cell and gene therapy development, particularly in immune system research. Advances in flow cytometry have enabled parallel characterization of multiple markers, supporting complex experiments. Manual analysis of such multiplexed experiments, requiring multiple different applications, prevents effective scaling. Replacing a legacy workflow with many different tools with a single, automated workflow in Genedata Screener, Evotec was able to increase efficiency and reduce data handling errors. This workflow can be easily adapted, enabling rapid and robust analysis of other flow cytometry data.
